Weaver C. Barksdale & Associates’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
Other funds holding SNV
SF
EAM
AL
Weaver C. Barksdale & Associates's SNV Position: Q4 2017 in Review
Weaver C. Barksdale & Associates reduced its Synovus (SNV) stake by 2.4% in Q4 2017, selling an estimated $189 and leaving 160 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #322.
Weaver C. Barksdale & Associates first reported a position in SNV in Q2 2013 and has held it in 19 quarters since. The position peaked at $12K in Q4 2013. 333 funds tracked by Wall St. Rank hold SNV as of Q4 2017.
- Weaver C. Barksdale & Associates held 160 shares of Synovus worth $8K as of Q4 2017.
- Weaver C. Barksdale & Associates sold 4 Synovus shares in Q4 2017, an estimated $189.
- Synovus made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #322 holding.
- Weaver C. Barksdale & Associates first reported a position in Synovus in Q2 2013 and has held it in 19 quarters since.
- Weaver C. Barksdale & Associates's Synovus position peaked at $12K in Q4 2013.
- 333 funds tracked by Wall St. Rank held Synovus as of Q4 2017.
Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.